Incidence and risk factors for lower limb lymphedema associated with endometrial cancer: Results from a prospective, longitudinal cohort study.

[1]  Susan J. Gordon,et al.  A Bioimpedance Spectroscopy-Based Method for Diagnosis of Lower-Limb Lymphedema. , 2020, Lymphatic research and biology.

[2]  K. Ushijima,et al.  Risk factors for lower limb lymphedema in gynecologic cancer patients after initial treatment , 2020, International Journal of Clinical Oncology.

[3]  D. Alberts,et al.  GOG 244 - The LymphEdema and Gynecologic cancer (LEG) study: The association between the gynecologic cancer lymphedema questionnaire (GCLQ) and lymphedema of the lower extremity (LLE). , 2019, Gynecologic oncology.

[4]  R. Newton,et al.  The Exercise and Sports Science Australia position statement: Exercise medicine in cancer management. , 2019, Journal of science and medicine in sport.

[5]  C. Friedenreich,et al.  Physical Activity and Mortality in Cancer Survivors: A Systematic Review and Meta-Analysis , 2019, JNCI cancer spectrum.

[6]  S. Mclaughlin,et al.  A Randomized Trial Evaluating Bioimpedance Spectroscopy Versus Tape Measurement for the Prevention of Lymphedema Following Treatment for Breast Cancer: Interim Analysis , 2019, Annals of Surgical Oncology.

[7]  J. Armer,et al.  Effects of weight-lifting or resistance exercise on breast cancer-related lymphedema: A systematic review , 2018, International journal of nursing sciences.

[8]  M. Hallek,et al.  Does Exercise Have a Preventive Effect on Secondary Lymphedema in Breast Cancer Patients Following Local Treatment - A Systematic Review , 2018, Breast Care.

[9]  E. Guirro,et al.  Intra- and Inter-Rater Reliability of Bioimpedance in the Evaluation of Lymphedema Secondary to Treatment of Breast Cancer. , 2017, Lymphatic research and biology.

[10]  M. Quinn,et al.  Lymphedema following gynecological cancer: Results from a prospective, longitudinal cohort study on prevalence, incidence and risk factors. , 2017, Gynecologic oncology.

[11]  N. Biglia,et al.  Lower Body Lymphedema in Patients with Gynecologic Cancer. , 2017, Anticancer research.

[12]  M. Fredrikson,et al.  Lymphedema after treatment for endometrial cancer - A review of prevalence and risk factors. , 2017, European journal of obstetrics, gynecology, and reproductive biology.

[13]  Ahmedin Jemal,et al.  Global Cancer in Women: Burden and Trends , 2017, Cancer Epidemiology, Biomarkers & Prevention.

[14]  M. Rettenmaier,et al.  Lower-extremity lymphedema following management for endometrial and cervical cancer. , 2016, Surgical oncology.

[15]  K. Refshauge,et al.  Risk factors for lymphoedema in women with breast cancer: A large prospective cohort. , 2016, Breast.

[16]  E. Darai,et al.  Endometrial cancer , 2016, The Lancet.

[17]  S. Sudo,et al.  Close relationship between removal of circumflex iliac nodes to distal external iliac nodes and postoperative lower-extremity lymphedema in uterine corpus malignant tumors. , 2015, Gynecologic oncology.

[18]  L. Ward,et al.  The Lymphedema Evaluation in Gynecological cancer Study (LEGS): Design of a prospective, longitudinal, cohort study , 2015 .

[19]  G. Schmid-Schönbein,et al.  Cellular and molecular basis of Venous insufficiency , 2014, Vascular cell.

[20]  B. Mehrara,et al.  Lymphedema and Obesity: Is There a Link? , 2014, Plastic and reconstructive surgery.

[21]  M. Quinn,et al.  Quality of life of women with lower limb swelling or lymphedema 3-5 years following endometrial cancer. , 2014, Gynecologic oncology.

[22]  K. Schmitz,et al.  Physical activity and lower limb lymphedema among uterine cancer survivors. , 2013, Medicine and science in sports and exercise.

[23]  B. Newman,et al.  Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis. , 2013, The Lancet. Oncology.

[24]  J. Cleland,et al.  Causes and treatment of oedema in patients with heart failure , 2013, Nature Reviews Cardiology.

[25]  M. Dodd,et al.  Comparison of diagnostic accuracy of clinical measures of breast cancer-related lymphedema: area under the curve. , 2011, Archives of physical medicine and rehabilitation.

[26]  Y. Todo,et al.  Risk factors for postoperative lower-extremity lymphedema in endometrial cancer survivors who had treatment including lymphadenectomy. , 2010, Gynecologic oncology.

[27]  J. Armer,et al.  Post-breast cancer lymphedema: incidence increases from 12 to 30 to 60 months. , 2010, Lymphology.

[28]  V. Torri,et al.  Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. , 2009, Journal of the National Cancer Institute.

[29]  H. Sasaki,et al.  Risk factors for lower limb lymphedema after lymph node dissection in patients with ovarian and uterine carcinoma , 2009, BMC Cancer.

[30]  Michael J Kallan,et al.  Lymphedema in breast cancer survivors: incidence, degree, time course, treatment, and symptoms. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[31]  M. Parmar,et al.  Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study , 2009, The Lancet.

[32]  L. Ferrucci,et al.  Sarcopenic obesity: definition, cause and consequences , 2008, Current opinion in clinical nutrition and metabolic care.

[33]  Monika Janda,et al.  Lymphedema after breast cancer: incidence, risk factors, and effect on upper body function. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[34]  B. Popkin,et al.  The altered fluid distribution in obesity may reflect plasma hypertonicity , 2007, European Journal of Clinical Nutrition.

[35]  R. Barakat,et al.  The incidence of symptomatic lower-extremity lymphedema following treatment of uterine corpus malignancies: a 12-year experience at Memorial Sloan-Kettering Cancer Center. , 2006, Gynecologic oncology.

[36]  H. Sasaki,et al.  Radiotherapy negates the effect of retroperitoneal nonclosure for prevention of lymphedema of the legs following pelvic lymphadenectomy for gynecological malignancies: an analysis from a questionnaire survey , 2006, International Journal of Gynecologic Cancer.

[37]  J. Beebe-Dimmer,et al.  The epidemiology of chronic venous insufficiency and varicose veins. , 2005, Annals of epidemiology.

[38]  B. Newman,et al.  Comparison of methods to diagnose lymphoedema among breast cancer survivors: 6-month follow-up , 2005, Breast Cancer Research and Treatment.

[39]  E. Slaytor,et al.  Aetiology and prevalence of lower limb lymphoedema following treatment for gynaecological cancer , 2003, The Australian & New Zealand journal of obstetrics & gynaecology.

[40]  L C Ward,et al.  Early diagnosis of lymphedema using multiple frequency bioimpedance. , 2001, Lymphology.

[41]  D. Larson,et al.  Pelvic and Para‐Aortic Lymphadenectomy for Surgical Staging of Endometrial Cancer: Morbidity and Mortality , 1992, Obstetrics and gynecology.

[42]  S. Heymsfield,et al.  Relative expansion of extracellular fluid in obese vs. nonobese women. , 1991, The American journal of physiology.

[43]  Gretchen A. Stevens,et al.  Global burden of cancer attributable to high body-mass index in 2012: a population-based study. , 2015, The Lancet. Oncology.

[44]  Seung Hyun Chung,et al.  Postoperative Lower Extremity Edema in Patients with Primary Endometrial Cancer , 2015, Annals of Surgical Oncology.

[45]  Monika Janda,et al.  Incidence, risk factors and estimates of a woman's risk of developing secondary lower limb lymphedema and lymphedema-specific supportive care needs in women treated for endometrial cancer. , 2015, Gynecologic oncology.